ArticleJournal of inflammation research2025
Construction of a Risk Score Model for Predicting Airway Management in Maxillofacial and Neck Region Space Infections Using Inflammatory Markers.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Patients with oral and maxillofacial space infections (OMSI) often experience rapidly progressing disease that can result in acute hypoxia, leading to severe complications such as cerebral hypoxia and cardiac arrest. Effective airway management (intubation or tracheotomy) is crucial in these cases. However, no validated tools currently exist to predict which patients require airway intervention. This study aimed to develop and validate a risk scoring system to predict the need for airway management in patients with OMSI. Patients and Methods: We conducted a retrospective study of OMSI patients treated between January 2020 and December 2022 and divided them into training and validation cohorts. A risk prediction model was developed using LASSO and logistic regression analyses in the training cohort, and its discrimination and calibration were verified in the validation cohort. Results: A total of 215 patients (150 for training and 65 for validation) were analyzed. Six independent predictors were identified: dyspnea (OR 3.95, 95% CI 1.38-11.35, p = 0.011), BMI (OR 1.14, 95% CI 1.04-1.25, p = 0.006), body temperature (OR 2.92, 95% CI 1.34-6.37, p = 0.007), sIL-2R level (OR 1.01, 95% CI 1.01-1.01, p = 0.007), CRP level (OR 1.01, 95% CI 1.01-1.01, p = 0.047), and retropharyngeal space involvement (OR 15.71, 95% CI 3.36-73.40, p < 0.001). Internal validation revealed good discrimination (AUC 0.91) and calibration (HL test, p = 0.061), with similar performance in the validation cohort (AUC 0.86; HL test, p = 0.133). Decision curve analysis demonstrated clinical utility in both cohorts. Conclusion: The proposed risk scoring system reliably predicts the need for airway management in OMSI patients, which enables clinicians to identify high-risk patients early and implement preventive strategies to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.